Why TRT Makes Your High Estrogen Worse (Doctors Won't Tell You)

Watch the full video on Rumble: https://rumble.com/v7fccxq-why-trt-makes-your-high-estrogen-worse-doctors-wont-tell-you.html

Why More Testosterone Can Leave You Feeling Worse Than Before

So your doctor is going to say, oh, you have low testosterone, you're a good candidate for TRT. What are they going to do? They're going to give you more testosterone.

That works, in the narrow sense that your total testosterone number on the next blood panel will be higher than it was. But the number was never the whole system, and the system is where the problem lives.

Here is the chain. Your body makes testosterone, some of it gets used as testosterone, and some of it gets converted into estradiol, which is the main form of estrogen in men, by an enzyme called aromatase. That enzyme sits in fat tissue, in the liver, in the brain, and in the testes, and its whole job is to take an androgen and turn it into an estrogen.

That conversion is not a defect. Estradiol drives growth plate closure and the maintenance of bone mineral density in adult men, not testosterone acting alone (Tenuta et al., 2025).

So the goal was never zero estrogen. The goal is a ratio your body can work with.

Now think about aromatase as a conversion rate rather than a switch. Two men can be handed the exact same dose and land in completely different places, because one is converting a small slice of it and the other is converting a much bigger slice. The enzyme lives in fat tissue, which is why body composition changes the math, and it is also expressed in the gonads themselves, where it has been conserved across vertebrate species for a very long time (Rosati et al., 2021).

But what it's also going to do is make you more predisposed to the side effects related to high E2, because you're already over-converting the testosterone to estrogen.

I want to be careful there, because that is what I see in practice and not what a trial has proven. I have never seen a study that took men with high baseline conversion, gave them testosterone, and tracked whether their symptoms got worse than everyone else's.

Adding more is just going to add more fuel to the fire, elevating your E2 even higher, making you feel even worse.

Think about pouring water into a bucket with a hole in the side. Pour faster and the level does come up, but the amount running out of the hole goes up proportionally, and if the hole is what was bothering you in the first place, more water is not the fix.

So what do you do with this.

Get estradiol measured before anyone touches your testosterone, not six months into a protocol when something already feels off. Ask for the sensitive assay, sometimes written as LC-MS or ultrasensitive estradiol, because the standard immunoassay was built for the much higher levels in women and it is unreliable at male ranges.

Then look at both numbers together. A man at 350 total testosterone with a proportionally normal estradiol is in a different situation from a man at 350 whose estradiol is pushing the top of the range, and those two should not get the same protocol even though their testosterone results look identical.

If you are carrying extra body fat, that is the lever with the least downside, because you are lowering how much enzyme is available to do the converting rather than blocking the enzyme after the fact.

And if you are already on testosterone and feel worse than you did before you started, that is information. It is telling you something about how your body handles the dose, and the answer is rarely to push the dose higher and hope the feeling catches up.

Low testosterone on a lab report is a result, not a cause. Whatever produced that result is still running when the injections start.

Research: Tenuta et al., J Clin Endocrinol Metab, 2025; Rosati et al., Animals, 2021.

References:

Tenuta M, Hasenmajer V, Gianfrilli D et al.. Testosterone and Male Bone Health: A Puzzle of Interactions. J Clin Endocrinol Metab. 2025. https://pubmed.ncbi.nlm.nih.gov/40120082/

Iorga A, Cunningham CM, Moazeni S et al.. The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy. Biol Sex Differ. 2017. https://pubmed.ncbi.nlm.nih.gov/29065927/

Rosati L, Falvo S, Chieffi Baccari G et al.. The Aromatase-Estrogen System in the Testes of Non-Mammalian Vertebrates. Animals (Basel). 2021. https://pubmed.ncbi.nlm.nih.gov/34204693/